# Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy

> **NCT02864615** · NA · COMPLETED · sponsor: **Kidney Cancer Research Bureau** · enrollment: 17 (actual)

## Conditions studied

- Metastatic Renal Cell Carcinoma

## Interventions

- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT02864615
- **Lead sponsor:** Kidney Cancer Research Bureau
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2018-01
- **Final completion:** 2018-08
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02864615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02864615, "Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02864615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*